Yukinori Nagakura

Astellas Pharma (Japan)Japan

Recent publications: 1. Watabiki T, Nagakura Y*, Wegner K, Kakimoto S, Tozier NA, Malkmus SA, Yaksh TL. Assessment of canine sensory function by using sine-wave electrical stimuli paradigm. Physiol Behav 101:327-330, 2010. 2. Oe T, Tsukamoto M, Nagakura Y*. Reserpine causes biphasic nociceptive sensitivity alteration in conjunction with brain biogenic amine tones in rats. Neuroscience 169:1860-1871, 2010. 3. Nagakura Y*, Oe T, Aoki T, Matsuoka N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain 146:26-33, 2009. 4. Nagakura Y, Jones TL, Malkmus SA, Sorkin L, Yaksh TL*. The sensitization of a broad spectrum of sensory nerve fibers in a rat model of acute postoperative pain and its response to intrathecal pharmacotherapy. Pain 139 569-577, 2008. 5. Kakimoto S*, Nagakura Y, Tamura S, Watabiki T, Shibasaki K, Tanaka S, Mori M, Sasamata M, Okada M. Minodronic acid, a third generation bisphosphonate, antagonizes purinergic P2X2/3 receptor function and exerts an analgesic effect in pain models. Eur J Pharmacol 589:98-101, 2008. 6. Nagakura Y, Malkmus S, Yaksh TL*. Determination of current threshold for paw withdrawal with sine-wave electrical stimulation in rats: Effect of drugs and alteration in acute inflammation. Pain 134:293-301, 2008. 7. Nagakura Y*, Kakimoto S, Matsuoka N. Purinergic P2X receptor activation induces emetic responses in ferrets and Suncus murinus (house musk shrews). Br J Pharmacol 152:464-70, 2007. 8. Kohara A*, Nagakura Y, Kiso T, Toya T, Watabiki T, Tamura S, Shitaka Y, Itahana H, Okada M. Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models. Eur J Pharmacol 571:8-16, 2007.

1chapters authored